NGL Fine-Chem Limited
NGL Fine-Chem Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: NGLFINE and BSE: 524774 (ISIN INE887E01022).
It has a market capitalisation of ₹1,713 crore, a last close of ₹2,773 on 2026-10-19, a one-year return of 82.7%.
Valuation: a price-to-earnings ratio of 29.95x, a price-to-book ratio of 5.20x, a dividend yield of 0.1%.
Profitability: return on equity of 0.0%, return on capital employed of 19.1%, an operating margin of 15.7%.
Growth: sales growth of 21.7% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.33x, promoter holding of 72.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 1,713 |
| Last close | ₹2,773 |
| P/E (TTM) | 29.95x |
| P/B | 5.20x |
| Dividend yield | 0.1% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 19.1% |
| Operating margin (TTM) | 15.7% |
| Sales growth, 3-year CAGR | 21.7% |
| Debt / equity | 0.33x |
| Promoter holding | 72.5% |
| 1-year return | 82.7% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means